Previous Pradaxa Settlement Gives Hope To Xarelto Lawsuit Plaintiffs

BloodThinnerHelp.com reports on the consolidation of the numerous lawsuits that have been filed against the manufacturers of Xarelto, Janssen Pharmaceuticals a subsidiary company of the Johnson and Johnson Corporation and Bayer AG. The U.S. Judicial Panel on Multidistrict Litigation (JPMDL) decreed that since the cases filed were strikingly similar in the allegations being leveled at the manufacturers related to the onset of uncontrollable bleeding, it consolidated the cases together, which now number over 2,800 complaints. In the month of August 2015 alone, the cases included in the multidistrict litigation (MDL) have grown by 400 cases and are expected to increase further.

Plaintiffs in the Xarelto cases are encouraged by actions taken with another new-generation blood thinner called Pradaxa that shares many similarities with the drug Xarelto. Pradaxa was released on the market for use by consumers in 2010 by Boehringer Ingelheim. As is the case with Xarelto, Pradaxa became the focus of public attention, as it was the subject of over 3,500 adverse event reports with fatalities involved in over 750 of them and subsequently became the focus of over 4,000 lawsuits. Rather than go to trial, Pradaxa's maker opted to settle all the lawsuits with a $650 million settlement. It is the hope of many of the plaintiffs in the Xarelto cases that they will also be in receipt of a settlement by the makers of Xarelto.

The MDL cases are steadily progressing toward litigation at this time. Judge Fallon required that by January 11, 2016, 40 cases be selected to form a pool from which 4 final cases will be chosen to be prepared for bellwether trials in Spring of 2017.

It should be noted as well that in addition to the cases in MDL 2592, there is an additional group of lawsuits in excess of 550 that were consolidated into a mass tort program by the Court of Common Pleas in Philadelphia, PA. All plaintiffs in these cases have named Janssen and Bayer AG as defendants as well.

The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.